Research

NCT07072728 - Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder

Clinical Trial in Abbotsford, Victoria

This study is assessing the efficacy and safety of NPX-5 in psilocybin-assisted psychotherapy for the treatment of adjustment disorder due to cancer diagnosis. Who is it for? This study is for people who are aged between 18 and 80 years old and suffer from anxiety after adjusting to an acutely stressful event of their cancer diagnosis. This is called adjustment disorder. Study details Participants in this study wi... Source record lists lead sponsor Psyence Australia Pty Ltd and overall status Recruiting.

Clinical TrialResearch
NCT07072728 - Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder

What They List

  • Psilocybin Clinical Trial
  • Study Screening Information
  • Research Participation Details

Directory Facts

Status
Verified from official/source records
Price
Free study screening / research participation
Hours
Verify with provider
License / Record
NCT07072728
Last Verified
2026-06-12

Location

Mind Medicine Australia Clinic, Abbotsford, Victoria

Source Notes

Discovery row generated from the official ClinicalTrials.gov API record for NCT07072728; status Recruiting; sponsor Psyence Australia Pty Ltd.

Source: https://clinicaltrials.gov/study/NCT07072728

Informational listing only.

MagicMushroomsDirectory does not provide medical, legal, or purchasing advice. Verify current laws, provider status, and eligibility before contacting any listing.